Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-α expression is neuroprotective after intracerebral hemorrhage

被引:148
作者
Mayne, M
Ni, W
Yan, HJ
Xue, M
Johnston, JB
Del Bigio, MR
Peeling, J
Power, C
机构
[1] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada
[3] Univ Calgary, Dept Clin Neurosci Microbiol & Infect Dis, Calgary, AB, Canada
关键词
behavior; intracerebral hemorrhage; neuronal death; oligodeoxyribonucleotide; antisense; tumor necrosis factor;
D O I
10.1161/01.STR.32.1.240
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Tumor necrosis factor-alpha (TNF-alpha) expression is increased in brain after cerebral ischemia, although little is known about its abundance and role in intracerebral hemorrhage (ICH). A TNF-alpha -specific antisense oligodeoxynucleotide (ORF4-PE) was used to study the extent to which TNF-alpha expression influenced neurobehavioral outcomes and brain damage in a collagenase-induced ICH model in rat. Methods-Male Sprague-Dawley rats were anesthetized, and ICH was induced by intrastriatal administration of heparin and collagenase. Immediately before or 3 hours after ICH induction, ORF4-PE was administered directly into the site of ICH. TNF-alpha mRNA and protein levels were measured by reverse transcriptase-polymerase chain reaction and immunoblot analyses. Cell death was measured by terminal deoxynucleotidyl transferase-mediated uridine 5' triphosphate-biotin nick end labeling (TUNEL), Neurobehavioral deficits were measured for 4 weeks after ICH. Results-ICH induction (n=6) elevated TNF-alpha mRNA and protein levels (P<0.01) at 24 hours after the onset of injury compared with sham controls (n=6). Immunohistochemical labeling indicated that ICH was accompanied by elevated expression of TNF-<alpha> in neutrophils, macrophages, and microglia. Administration of ORF4-PE (2.0 nmol) directly into striatal parenchyma, 15 minutes before (n=4) or 3 hours after (n=6) ICH, decreased levels of TNF-alpha mRNA (P<0.001) and protein (P<0.01) in the brain tissue surrounding the hematoma compared with animals treated with saline alone (n=6). Mean+/-SEM striatal cell death (cells per high-powered field) was also reduced in animals receiving ORF4-PE (34.1+/-5.0) compared with the saline-treated ICH group (80.3+/-7.50) (P<0.001). ORF4-PE treatment improved neurobehavioral deficits observed at 24 hours (P<0.001) after induction of ICH (n=6) compared with the untreated ICH group (n=6). This improvement was maintained at 28 days after hemorrhage induction (P<0.001). Conclusions-These results indicate a pathogenic role for TNF-<alpha> during ICH and demonstrate that reducing TNF-alpha expression using antisense oligodeoxynucleotides is neuroprotective.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 40 条
[1]   Brain injury and inflammation - A putative role of TNF alpha [J].
Arvin, B ;
Neville, LF ;
Barone, FC ;
Feuerstein, GZ .
NEUROPROTECTIVE AGENTS: CLINICAL AND EXPERIMENTAL ASPECTS, 1995, 765 :62-71
[2]   The role of inflammation and cytokines in brain injury [J].
Arvin, B ;
Neville, LF ;
Barone, FC ;
Feuerstein, GZ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1996, 20 (03) :445-452
[3]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[4]   Tumor necrosis factor-alpha - A mediator of focal ischemic brain injury [J].
Barone, FC ;
Arvin, B ;
White, RF ;
Miller, A ;
Webb, CL ;
Willette, RN ;
Lysko, PG ;
Feuerstein, GZ .
STROKE, 1997, 28 (06) :1233-1244
[5]   TUMOR-NECROSIS-FACTOR PRODUCTION AND RECEPTOR EXPRESSION BY A HUMAN-MALIGNANT GLIOMA CELL-LINE, D54-MG [J].
BETHEA, JR ;
GILLESPIE, GY ;
CHUNG, IY ;
BENVENISTE, EN .
JOURNAL OF NEUROIMMUNOLOGY, 1990, 30 (01) :1-13
[6]  
Brown RD, 1996, STROKE, V27, P373
[7]   Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors [J].
Bruce, AJ ;
Boling, W ;
Kindy, MS ;
Peschon, J ;
Kraemer, PJ ;
Carpenter, MK ;
Holtsberg, FW ;
Mattson, MP .
NATURE MEDICINE, 1996, 2 (07) :788-794
[8]   The Tat protein of HIV-1 induces tumor necrosis factor-alpha production - Implications for HIV-1-associated neurological diseases [J].
Chen, PQ ;
Mayne, M ;
Power, C ;
Nath, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22385-22388
[9]   DIFFERENTIAL TUMOR-NECROSIS-FACTOR-ALPHA EXPRESSION BY ASTROCYTES FROM EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS-SUSCEPTIBLE AND ENCEPHALOMYELITIS-RESISTANT RAT STRAINS [J].
CHUNG, IY ;
NORRIS, JG ;
BENVENISTE, EN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :801-811
[10]   The problem of assessing effective neuroprotection in experimental cerebral ischemia [J].
Corbett, D ;
Nurse, S .
PROGRESS IN NEUROBIOLOGY, 1998, 54 (05) :531-548